Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): A case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease

Cerebrovascular Diseases

Volumn 15, Issue 1-2, 2003, Pages 11-16

  Ngeh, Joseph ^a,b   Gupta, Sandeep ^b   Goodbourn, Colin ^b   Panayiotou, Barnabas ^a   McElligott, Geraldine ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Cerebrovascular disease; Chlamydia pneumoniae; Elderly; Seroprevalence; Stroke

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE DISEASE; AGE; AGED; ANAMNESIS; ARTICLE; CAUCASIAN; CEREBROVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENDER; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFECTION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SEROPREVALENCE; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISCHEMIC ATTACK, TRANSIENT; LONDON; MALE; MYOCARDIAL ISCHEMIA; RECURRENCE; SEROEPIDEMIOLOGIC STUDIES; STATISTICS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037243335     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067115     Document Type: Article

References (27)

1. Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK: Preceding infection as an important risk factor for ischaemic brain infarction in young and middle-aged patients. Br Med J 1988;296:1156-1160.
2. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, Rohlfs M, Suhr H, Fiehn W, Becher H, Hacke W: Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995;26:373-379.
3. Ngeh JKT: Chlamydia pneumoniae in elderly patients with stroke study (CPEPS): A case-control study on the seroprevalence of Chlamydia pneumoniae in patients aged over 65 years admitted with acute stroke or transient ischaemic attack; thesis, Keele, 2000.
4. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL: Association of chlamydial infection with cerebrovascular disease. Stroke 1996;27:2207-2210.
5. Cook PJ, Honeybourne D, Lip GYH, Beevers DG, Wise R, Davies P: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project. Stroke 1998;29:404-410.
6. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: A prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999;30:299-305.
7. Glader CA, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, Dahlen G: Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. Stroke 1999;30:2013-2018.
8. Elkind MSV, Lin I-F, Grayston JT, Sacco RL: Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000;31:1521-1525.
9. Kawashima N, Kawada J: Chlamydia pneumoniae antibody titers in patients with acute ischemic stroke (in Japanese). Rinsho Shinkeigaku 2000;40:1063-1068.
10. Heuschmann P, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas P: Association between infection with Helicobacter pyloriand Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke 2001;32:2253-2258.
11. Wolf PA: Prevention of stroke. Lancet 1998;352(suppl 3):15-18.
12. Warlow CP: Epidemiology of stroke. Lancet 1998;352(suppl 3):1-4.
13. World Health Organisation: Cerebrovascular disease: A clinical and research classification. WHO Offset Publ 43, 1978.
14. Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T: Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol 1991;29:816-818.
15. Wang JH, Liu YC, Cheng DL, Yeng MY, Chen YS, Chen BC: Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993;25:565-568.
16. Paltiel O, Kark JD, Leinonen M, Saikku P: High prevalence of antibodies to Chlamydia pneumoniae: Determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect 1995;114:465-473.
17. Woodward M: Formulae for sample size, power and minimum detectable relative risk in medical studies. Statistician 1992;41:185-196.
18. Ngeh J, Gupta S: Inflammation, infection and antimicrobial therapy in coronary heart disease - where do we currently stand? Fundam Clin Pharmacol 2001;15:85-93.
19. Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D: Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pyloriand cytomegalovirus are not. Epidemiol Infect 1998;120:93-99.
20. Tavendale R, Parratt D, Brook RA, Tunstall-Pedoe H: Antibodies to Chlamydia pneumoniae do not predict subsequent CHD in the Scottish Heart Health and MONICA studies. Eur Heart J 1999;20(suppl):450.
21. Ngeh J, Gupta S: Chlamydia pneumoniae infection and atherosclerotic vascular disease: Causal or coincidental link? ASM News 2000;66:732-737.
22. Tompkins LS, Schachter J, Boman J, Dowell S, Gaydos CA, Levison ME, Maass M, Madico G, Orfila J, Ouchi K, Peeling RW, Taylor-Robinson D, Stamm WE, Wang SP, Blasi F, Relman D: Collaborative multidisciplinary workshop report: Detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae. J Infect Dis 2000;181:S460-461.
23. Leinonen M: Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993;14(suppl K):57-61.
24. Einarsson S, Sigurdsson HK, Magnusdottir SD, Erlendsdottir H, Briem H, Gudmundsson S, et al.: Age-specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 1994;26:393-397.
25. Coles KA, Plant AJ, Riley TV, Smith DW, McQuillan BM, Thompson PL: Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. Am J Cardiol 1999;84:825-828.
26. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW: Seasonal variation of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease. Lancet 1994;343:435-439.
27. Stout RW: Atherosclerosis and lipid metabolism; in Tallis RC, Fillit HM, Brocklehurst JC (eds): Brocklehurst's Textbook of Geriatric Medicine and Gerontology. New York, Churchill Livingstone, 1998, ed 5, pp 263-279.